Capital will fund Castle Creek’s D-Fi Phase 3 clinical trial for patients with dystrophic epidermolysis bullosa through ...

Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) These FDA ...

Risk of Serious Injection Site Reactions: Likelihood of may increase with inadvertent intramuscular or intradermal administration. Evaluate and treat as appropriate. The most common injection ...

Apimeds Pharmaceuticals US (APUS) plans to raise $20 million in an initial public offering (IPO) on the week of March 10th, IPO Scoop reports. The company will issue 4,500,000 shares at $4.00-$5.00 ...

Vaccine Technologies Market 2025 market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare ...

Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of March 10th, IPO Scoop reports. The company will issue 4,500,000 shares at a price of $4.

Thimerosal-allergic patients were challenged with three intramuscular injections of thimerosal solution (100 µg/mL) into the arm; if no reaction was observed, the dosage was increased (to 0.1 mL ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported 2024 financial and operational ...

When people are allergic to tree, grass, and herb pollen, this is known as hay fever. But did you know that our animals also develop such allergies? PETBOOK explains how to tell if your dog or cat is ...